Jaworski, C., Iliev, P., Wängler, C., Wängler, B., Page, B., Schirrmacher, R., & Bailey, J. (2023). Type I inhibitors of tropomyosin receptor kinase (Trk): A 2020-2022 patent update. Expert opinion on therapeutic patents, 33(7-8), . https://doi.org/10.1080/13543776.2023.2262136
Chicago-Zitierstil (17. Ausg.)Jaworski, Carolin, Petar Iliev, Carmen Wängler, Björn Wängler, Brent Page, Ralf Schirrmacher, und Justin Bailey. "Type I Inhibitors of Tropomyosin Receptor Kinase (Trk): A 2020-2022 Patent Update." Expert Opinion on Therapeutic Patents 33, no. 7-8 (2023). https://doi.org/10.1080/13543776.2023.2262136.
MLA-Zitierstil (9. Ausg.)Jaworski, Carolin, et al. "Type I Inhibitors of Tropomyosin Receptor Kinase (Trk): A 2020-2022 Patent Update." Expert Opinion on Therapeutic Patents, vol. 33, no. 7-8, 2023, https://doi.org/10.1080/13543776.2023.2262136.